Instant Immunity: Preventing RSV Infections
- According to data presented today, September 26, 2025, by Dr.
- Medical education from numerous countries highlights Nirsevimab as a highly effective preventative measure against RSV infections.Three studies have demonstrated that Nirsevimab reduces the risk of hospitalization due to...
- Data tracking within Thailand identifies specific risk factors for severe RSV illness requiring hospitalization.These include children under two years of age, particularly those with chronic lung disease stemming...
Thailand reports RSV Risks in Infants, Nirsevimab Shows high Efficacy
Table of Contents
Published September 26, 2025, at 09:59 AM
RSV Threat to Infants in Thailand
According to data presented today, September 26, 2025, by Dr. thanin Vejjachapinan, Deputy Director-General of the Department of Medical services, Thailand faces a significant risk of Respiratory Syncytial Virus (RSV) infections in infants. Educational data indicates a mortality rate of 1.75 per 100,000 children under one year old due to RSV, exceeding rates observed in older age groups.
Nirsevimab: A Promising Preventative Measure
Medical education from numerous countries highlights Nirsevimab as a highly effective preventative measure against RSV infections.Three studies have demonstrated that Nirsevimab reduces the risk of hospitalization due to RSV infection by up to 81%.The most recent study showed peak protection performance of 79.3% within the two weeks following injection.
Data tracking within Thailand identifies specific risk factors for severe RSV illness requiring hospitalization.These include children under two years of age, particularly those with chronic lung disease stemming from premature birth, and children with pre-existing chronic health conditions. These vulnerable groups stand to benefit most from preventative interventions like Nirsevimab.
Risk Factors and Vulnerable Populations
The following table summarizes the key risk factors identified in Thailand:
| Risk Factor | Description |
|---|---|
| Age | Children under 2 years old are at highest risk. |
| Prematurity | Infants born prematurely with chronic lung disease. |
| Chronic Illness | Children with pre-existing chronic health conditions. |